PITUITARY CANCER METASTATIC

PITUITARY CANCER METASTATIC was reported 19 times

PITUITARY CANCER METASTATIC is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Somatostatin Analog [EPC] 3 0.0004
1 Progestin Antagonist [EPC] 2 0.0004
2 Ergot Derivative [EPC] 1 0.0002
3 Recombinant Human Growth Hormone [EPC] 1 0.0000
4 Androgen [EPC] 1 0.0000
5 HER2/neu Receptor Antagonist [EPC] 2 0.0000
6 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
7 Microtubule Inhibitor [EPC] 2 0.0000
8 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
9 Aldosterone Antagonist [EPC] 1 0.0000
10 Azole Antifungal [EPC] 1 0.0000
11 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
12 Alkylating Drug [EPC] 1 0.0000
13 Opioid Agonist [EPC] 1 0.0000
14 Corticosteroid [EPC] 4 0.0000
15 Insulin Analog [EPC] 1 0.0000
16 Thalidomide Analog [EPC] 1 0.0000